デジタルバイオマーカーの世界市場

Report Highlights

The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.

Report Includes

• 53 data tables and 54 additional tables
• An overview of the global market for digital biomarkers
• Estimation of the market size and analyses of global market trends, with data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
• Information regarding major market drivers, opportunities and challenges, industry chain structure, distribution channel and technological advancements that are affecting the overall market
• Evaluation of market potential and revenue forecast for the digital biomarkers market based on system component, application, therapeutic area, end user and region
• Insights into the industry structure, current competitive scenario, R&D activities, growth strategies and ESG trends of the market
• Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, joint ventures and strategic alliances
• Profiles of the leading companies, including Actigraph LLC., AliveCor Inc., Altoida, Evidation Health Inc., and IXICO Plc.

Report Scope

This report provides an overview of the global market for digital biomarkers and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030. The market is segmented based on system components, applications, therapeutic areas, end users and regions. The regions covered in this study include North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries in these regions.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and governance (ESG) developments and discusses emerging technologies related to the market.

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview and Market Definition
Digital Biomarker Types
Comparison of Traditional and Digital Biomarkers
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Impact of U.S. Tariff Laws on the Digital Biomarkers Market
Increase in Product Costs
Effects on Supply Chain
Opportunities for Local Production
Conclusion
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Adoption of mHealth Apps and Wearables
Growing Application of Digital Biomarkers in Neurodegenerative and Psychiatric Disorders
Increasing Role of Digital Biomarkers in Clinical Trials
Corporate Wellness Programs and Incentives
Market Restraints
Data Standardization and Interpretation Issues
Difficulties in Validation of Biomarkers
Data Privacy and Protection
Market Opportunities
Growing Technology Innovations
Increasing Research Collaborations and Partnerships
Chapter 4 Regulatory Landscape
Regulatory Scenario
The U.S.
Canada
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Artificial Intelligence-based Digital Biomarkers
Enhancement of Digital Biomarkers by AI and ML
Benefits of AI-Driven Digital Biomarkers
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by System Component
Key Takeaways
Data Collection Tools
Data Integration Systems
Market Breakdown by Application
Key Takeaways
Diagnostic Digital Biomarkers
Monitoring Digital Biomarkers
Predictive Digital Biomarkers
Other Applications
Market Breakdown by Therapeutic Area
Key Takeaways
Cardiovascular and Metabolic Disorders
Psychiatric Disorders
Neurological Disorders
Musculoskeletal Disorders
Respiratory Disorders
Other Therapeutic Areas
Market Breakdown by End User
Key Takeaways
Pharmaceutical Companies and Research Institutions
Healthcare Providers
Patients and Caregivers
Employers
Payers
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Prominent Digital Biomarkers Companies
Competitor Types and Their Strategies
Pharmaceutical Companies
Large Technology Companies
Small and Medium-Size Technology Companies
Strategic Analysis
Agreements, Collaborations and Partnerships
New Product Launches
Acquisitions and Mergers
Regulatory Approvals
Chapter 8 Sustainability in Digital Biomarkers Market: ESG Perspective
Introduction
Sustainability Factors
Environmental Sustainability
Social Sustainability
Economic Sustainability
Other Factors
Scaling Sustainable Practices in Healthcare
Business Practices Implementing Sustainable Solutions
Conclusion
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ACTIGRAPH LLC.
AKILI INC.
ALIVECOR INC.
ALTOIDA
EMBIC CORP.
EMPATICA INC.
EVIDATION HEALTH INC.
FEEL THERAPEUTICS
HUMA
IXICO PLC
KINSA INC.
KONEKSA HEALTH
NEUROTRACK TECHNOLOGIES INC.
VIVOSENSMEDICAL GMBH
WINTERLIGHT LABS

List of Tables

List of Tables
Summary Table : Global Market for Digital Biomarkers, by Application, Through 2030
Table 1 : Digital Biomarker Types
Table 2 : Traditional and Digital Biomarker Comparison
Table 3 : Digital Biomarkers Examples
Table 4 : Technology Innovations by Digital Biomarker Companies
Table 5 : Key Research Collaborations and Partnerships, 2023–2025
Table 6 : Global Market for Digital Biomarkers, by System Component, Through 2030
Table 7 : Global Digital Biomarkers Market for Data Collection Tools, by Type, Through 2030
Table 8 : Global Digital Biomarkers Market for Data Collection Tools, by Region, Through 2030
Table 9 : Global Digital Biomarkers Market for Mobile and Web Apps, by Region, Through 2030
Table 10 : Global Digital Biomarkers Market for Wearables, by Region, Through 2030
Table 11 : Global Digital Biomarkers Market for Implantables and Ingestibles, by Region, Through 2030
Table 12 : Global Digital Biomarkers Market for Other Data Collection Tools, by Region, Through 2030
Table 13 : Global Digital Biomarkers Market for Data Integration Systems, by Region, Through 2030
Table 14 : Global Market for Digital Biomarkers, by Application, Through 2030
Table 15 : Global Market for Diagnostic Digital Biomarkers, by Region, Through 2030
Table 16 : Global Market for Monitoring Digital Biomarkers, by Region, Through 2030
Table 17 : Global Market for Predictive Digital Biomarkers, by Region, Through 2030
Table 18 : Global Market Other Applications of Digital Biomarkers, by Region, Through 2030
Table 19 : Global Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 20 : Global Digital Biomarkers Market for Cardiovascular and Metabolic Disorders, by Region, Through 2030
Table 21 : Global Digital Biomarkers Market for Psychiatric Disorders, by Region, Through 2030
Table 22 : Global Digital Biomarkers Market for Neurological Disorders, by Region, Through 2030
Table 23 : Global Digital Biomarkers Market for Musculoskeletal Disorders, by Region, Through 2030
Table 24 : Global Digital Biomarkers Market for Respiratory Disorders, by Region, Through 2030
Table 25 : Global Digital Biomarkers Market for Other Therapeutic Areas, by Region, Through 2030
Table 26 : Global Market for Digital Biomarkers, by End User, Through 2030
Table 27 : Global Digital Biomarkers Market for Pharmaceutical Companies and Research Institutions, by Region, Through 2030
Table 28 : Global Digital Biomarkers Market for Healthcare Providers, by Region, Through 2030
Table 29 : Global Digital Biomarkers Market for Patients and Caregivers, by Region, Through 2030
Table 30 : Global Digital Biomarkers Market for Employers, by Region, Through 2030
Table 31 : Global Digital Biomarkers Market for Payers, by Region, Through 2030
Table 32 : Global Market for Digital Biomarkers, by Region, Through 2030
Table 33 : North American Market for Digital Biomarkers, by System Component, Through 2030
Table 34 : North American Market for Data Collection Tools, by Type, Through 2030
Table 35 : North American Market for Digital Biomarkers, by Application, Through 2030
Table 36 : North American Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 37 : North American Market for Digital Biomarkers, by End User, Through 2030
Table 38 : North American Market for Digital Biomarkers, by Country, Through 2030
Table 39 : European Market for Digital Biomarkers, by System Component, Through 2030
Table 40 : European Market for Data Collection Tools, by Type, Through 2030
Table 41 : European Market for Digital Biomarkers, by Application, Through 2030
Table 42 : European Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 43 : European Market for Digital Biomarkers, by End User, Through 2030
Table 44 : European Market for Digital Biomarkers, by Country, Through 2030
Table 45 : Asia-Pacific Market for Digital Biomarkers, by System Component, Through 2030
Table 46 : Asia-Pacific Market for Data Collection Tools, by Type, Through 2030
Table 47 : Asia-Pacific Market for Digital Biomarkers, by Application, Through 2030
Table 48 : Asia-Pacific Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 49 : Asia-Pacific Market for Digital Biomarkers, by End User, Through 2030
Table 50 : Asia-Pacific Market for Digital Biomarkers, by Country, Through 2030
Table 51 : RoW Market for Digital Biomarkers, by System Component, Through 2030
Table 52 : RoW Market for Data Collection Tools, by Type, Through 2030
Table 53 : RoW Market for Digital Biomarkers, by Application, Through 2030
Table 54 : RoW Market for Digital Biomarkers, by Therapeutic Area, Through 2030
Table 55 : RoW Market for Digital Biomarkers, by End User, Through 2030
Table 56 : RoW Market for Digital Biomarkers, by Sub-Region, Through 2030
Table 57 : Prominent Digital Biomarkers Companies
Table 58 : Agreements, Collaborations and Partnerships in the Digital Biomarkers Market, 2023–2025
Table 59 : New Product Launches in the Digital Biomarkers Market, 2022–2025
Table 60 : Acquisitions and Mergers in the Digital Biomarkers Market, 2024 and 2025
Table 61 : Regulatory Approvals in the Digital Biomarkers Market, 2022–2025
Table 62 : Information Sources for this Report
Table 63 : Abbreviations Used in this Report
Table 64 : ActiGraph LLC.: Company Snapshot
Table 65 : ActiGraph LLC.: Product Portfolio
Table 66 : ActiGraph LLC.: News/Key Developments, 2023–2025
Table 67 : Akili Inc.: Company Snapshot
Table 68 : Akili Inc.: Product Portfolio
Table 69 : Akili Inc.: News/Key Developments, 2024
Table 70 : Alivecor Inc.: Company Snapshot
Table 71 : AliveCor Inc.: Product Portfolio
Table 72 : AliveCor Inc.: News/Key Developments, 2024 and 2025
Table 73 : Altoida: Company Snapshot
Table 74 : Altoida: Product Portfolio
Table 75 : Embic Corp.: Company Snapshot
Table 76 : Embic Corp.: Product Portfolio
Table 77 : Empatica Inc.: Company Snapshot
Table 78 : Empatica Inc.: Product Portfolio
Table 79 : Empatica Inc.: News/Key Developments, 2023 and 2024
Table 80 : Evidation Health Inc.: Company Snapshot
Table 81 : Evidation Health Inc.: Product Portfolio
Table 82 : Evidation Health Inc.: News/Key Developments, 2022–2024
Table 83 : Feel Therapeutics: Company Snapshot
Table 84 : Feel Therapeutics: Product Portfolio
Table 85 : Feel Therapeutics: News/Key Developments, 2022 and 2023
Table 86 : Huma: Company Snapshot
Table 87 : Huma: Product Portfolio
Table 88 : Huma: News/Key Developments, 2023–2025
Table 89 : IXICO plc: Company Snapshot
Table 90 : IXICO plc: Financial Performance, FY 2023 and 2024
Table 91 : IXICO plc: Product Portfolio
Table 92 : IXICO plc: News/Key Developments, 2024 and 2025
Table 93 : Kinsa Inc.: Company Snapshot
Table 94 : Kinsa Inc.: Product Portfolio
Table 95 : Kinsa Inc.: News/Key Developments, 2024
Table 96 : Koneksa Health: Company Snapshot
Table 97 : Koneksa Health: Product Portfolio
Table 98 : Koneksa Health: News/Key Developments, 2023 and 2024
Table 99 : Neurotrack Technologies Inc.: Company Snapshot
Table 100 : Neurotrack Technologies Inc.: Product Portfolio
Table 101 : Neurotrack Technologies Inc.: News/Key Developments, 2022
Table 102 : VivoSensMedical GmbH: Company Snapshot
Table 103 : VivoSensMedical GmbH: Product Portfolio
Table 104 : VivoSensMedical GmbH: News/Key Developments, 2021
Table 105 : Winterlight Labs: Company Snapshot
Table 106 : Winterlight Labs: Product Portfolio

List of Figures

List of Figures
Summary Figure : Global Market Share of Digital Biomarkers, by Application, 2024
Figure 1 : PESTEL Analysis: Digital Biomarkers Market
Figure 2 : Digital Biomarkers Market Dynamics
Figure 3 : Distribution of Clinical Trials with Digital Biomarkers as Endpoints, by Therapeutic Area
Figure 4 : Global Market Shares of Digital Biomarkers, by System Component, 2024
Figure 5 : Global Digital Biomarkers Market Share of Data Collection Tools, by Type, 2024
Figure 6 : Global Digital Biomarkers Market Share of Mobile and Web Apps, by Region, 2024
Figure 7 : Global Digital Biomarkers Market Share of Wearables, by Region, 2024
Figure 8 : Global Digital Biomarkers Market Share of Implantables and Ingestibles, by Region, 2024
Figure 9 : Global Digital Biomarkers Market Share of Other Data Collection Tools, by Region, 2024
Figure 10 : Global Digital Biomarkers Market Share of Data Integration Systems, by Region, 2024
Figure 11 : Global Market Share of Digital Biomarkers, by Application, 2024
Figure 12 : Global Market Share of Diagnostic Digital Biomarkers, by Region, 2024
Figure 13 : Global Market Share of Monitoring Digital Biomarkers, by Region, 2024
Figure 14 : Global Market Share of Predictive Digital Biomarkers, by Region, 2024
Figure 15 : Global Market Share of Other Applications of Digital Biomarkers, by Region, 2024
Figure 16 : Global Market Share of Digital Biomarkers, by Therapeutic Area, 2024
Figure 17 : Global Digital Biomarkers Market Share of Cardiovascular and Metabolic Disorders, by Region, 2024
Figure 18 : Global Digital Biomarkers Market Share of Psychiatric Disorders, by Region, 2024
Figure 19 : Global Digital Biomarkers Market Share of Neurological Disorders, by Region, 2024
Figure 20 : Global Digital Biomarkers Market Share of Musculoskeletal Disorders, by Region, 2024
Figure 21 : Global Digital Biomarkers Market Share of Respiratory Disorders, by Region, 2024
Figure 22 : Global Digital Biomarkers Market Share of Other Therapeutic Areas, by Region, 2024
Figure 23 : Global Market Share of Digital Biomarkers, by End User, 2024
Figure 24 : Global Digital Biomarkers Market Share of Pharmaceutical Companies and Research Institutions, by Region, 2024
Figure 25 : Global Digital Biomarkers Market Share of Healthcare Providers, by Region, 2024
Figure 26 : Global Digital Biomarkers Market Share of Patients and Caregivers, by Region, 2024
Figure 27 : Global Digital Biomarkers Market Share of Employers, by Region, 2024
Figure 28 : Global Digital Biomarkers Market Share of Payers, by Region, 2024
Figure 29 : Global Market Share of Digital Biomarkers, by Region, 2024
Figure 30 : North American Market Share of Digital Biomarkers, by Country, 2024
Figure 31 : U.S. Elderly* Population, 2010–2050
Figure 32 : European Market Share of Digital Biomarkers, by Country, 2024
Figure 33 : Asia-Pacific Market Share of Digital Biomarkers, by Country, 2024
Figure 34 : RoW Market Share of Digital Biomarkers, by Sub-Region, 2024
Figure 35 : Digital Biomarkers: Competitor Types and Their Strategies
Figure 36 : Sustainability Factors in the Digital Biomarkers Industry
Figure 37 : Scaling Sustainable Practices in Healthcare
Figure 38 : IXICO plc: Revenue Share, by Country/Region, FY 2024

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 世界の電気アーク炉市場 2025-11-07
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07

BCC Research  出版レポート一覧